Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Nude Mouse Models of Metastatic and Disseminated Human Ovarian Cancer

Journal of Cellular Biochemistry

Volumn 115, Issue 11, 2014, Pages 1996-2003

  Matsumoto, Yasunori ^a,b,c   Miwa, Shinji ^a,b   Zhang, Yong ^a   Hiroshima, Yukihiko ^a,b   Yano, Shuya ^a,b   Uehara, Fuminari ^a,b   Yamamoto, Mako ^a,b   Toneri, Makoto ^a,b   Bouvet, Michael ^b   Matsubara, Hisahiro ^c   Hoffman, Robert M ^a,b   Zhao, Ming ^a  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

BACTERIA; GFP; IMAGING; NUDE MICE; OVARIAN CANCER; Salmonella typhimurium; TUMOR TARGETING

Indexed keywords

A1 R; ANTIMETASTATIC AGENT; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; DISSEMINATED CANCER; DRUG EFFICACY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; MOUSE MODEL; NONHUMAN; OVARY METASTASIS; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM A1 R; SURVIVAL RATE; ANIMAL; CELL PROLIFERATION; CLASSIFICATION; DRUG SCREENING; NUDE MOUSE; OVARIAN NEOPLASMS; PATHOGENICITY; PATHOLOGY; PERITONEAL NEOPLASMS; SALMONELLOSIS; SECONDARY; SURVIVAL; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84941108749     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24871     Document Type: Article

References (32)

1. American Cancer Society. 2013. [ http://www.cancer.org/ ].
2. Bakrin N, Bereder JM, Decullier E,. 2013. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39: 1435-1443.
3. Buick RN, Pullano R, Trent JM,. 1985. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668-3676.
4. Cannistra SA, Bast RC, Jr, Berek JS,. 2003. Progress in the management of gynecologic cancer: Consensus summary statement. J Clin Oncol 21: 129s-132s.
5. Cascales-Campos P, Gil J, Parrilla P,. 2013. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer. Eur J Surg Oncol DOI: 10.1016/j.ejso.2013.08.013. [Epub ahead of print].
6. Cascales-Campos PA, Gil J, Gil E, Feliciangeli E, Gonzalez-Gil A, Parilla JJ, Parilla P,. 2014. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with Stage IIIC/IV ovarian cancer. Ann Surg Oncol 21: 2383-2389.
7. Fu X, Hoffman RM,. 1993. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 13: 283-286.
8. Goshima F, Esaki S, Luo C, Kamakura M, Kimura H, Nishiyama Y,. 2013. Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer. Int J Cancer 134: 2865-2877.
9. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF,. 1983. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43: 5379-5389.
10. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM,. 2009. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 8: 870-875.
11. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM,. 2013. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 12: 2774-2780.
12. Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM,. 2014. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem 115: 1254-1261.
13. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
14. Kiguchi K, Kubota T, Aoki D, Udagawa Y, Tamanouchi S, Saga M, Amemiya A, Sun FX, Nozawa S, Moossa AR, Hoffman RM,. 1998. A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer. Clin Exp Metastasis 16: 751-756.
15. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM,. 2010. Targeted therapy of spinal cord glioma with a genetically-modified Salmonella typhimurium. Cell Prolif 43: 41-48.
16. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S,. 2009. Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNFα. PLoS ONE 4: e6692.
17. Liu F, Zhang L, Hoffman RM, Zhao M,. 2010. Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 9: 4518-4524.
18. Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM,. 2012. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 11: 628-632.
19. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM,. 2009. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29: 1873-1878.
20. O'Malley DM, Richardson DL, Rheaume PS,. 2011. Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecol Oncol 121: 269-272.
21. Pawelek JM, Low KB, Bermudes D,. 2003. Bacteria as tumour-targeting vectors. Lancet Oncol 4: 548-556.
22. Siegel R, Naishadham D, Jemal A,. 2013. Cancer statistics. 2013. CA Cancer J Clin 63: 11-30.
23. Takakura M, Nakamura M, Kyo M, Hashimoto M, Mori N, Ikoma T, Mizumoto Y, Fujiwara T, Urata Y, Inoue M,. 2010. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination. Cancer Gene Ther 17: 11-19.
24. Tome Y, Zhang Y, Momiyama M, Maehara H, Kanaya F, Tomita K, Tsuchiya H, Bouvet M, Hoffman RM, Zhao M,. 2013. Primer dosing of S. typhimurium A1-R potentiates tumor-targeting and efficacy in immunocompetent mice. Anticancer Res 33: 97-102.
25. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA,. 2002. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20: 142-152.
26. Uchugonova A, Zhao M, Zhang Y, Weinigel M, König K, Hoffman RM,. 2012. Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice. Anticancer Res 32: 4331-4338.
27. Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, Bouvet M, Hoffman RM,. 2010. Monotherapy with a tumor-targeting mutant of S. typhimurium controls liver metastasis in a mouse model of pancreatic cancer. J Surg Res 164: 248-255.
28. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM,. 2006. Development of real-time subcellular dynamic multicolor imaging of cancer cell-trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 66: 4208-4214.
29. Yang SW, Chanda D, Cody JJ, Rivera AA, Waehler R, Siegal GP, Douglas JT, Pennazhagen S,. 2011. Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer. PLoS ONE 6: e25131.
30. Zhao M, Yang Y, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM,. 2005. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 102: 755-760.
31. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM,. 2006. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.
32. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM,. 2007. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 104: 10170-10174.